助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[4537]条 当前为第1条到20条[由于搜索限制,当前仅支持显示前5页数据]
 

相关语句
treated group
    【Methods】Ninety eight patients with SP were randomly assigned to three groups : treated group(Group A),thick pipe group(Group B) and thin pipe group(Group C).
    【方法】98例气胸病人随机分为治疗组(A组)、粗管组(B组)、细管组(C组)。
    Result: The therapeutic effect of the treated group is better than that of the control group(P<0.05~0.01).
    结果:治疗组疗效优于对照组(P<0.05-0.01)。
    However,22.8% of patients in the control group had YMDD variant HBV as compared with 3.03% in the treated group,and P value was <0.05.Conclusion:Thymosin-α1 combined with Lamivudine is effective for the patients with chronic hepatitis B and is valuable to be used in clinical.
    HBV YMDD变异株:治疗组仅有1例(3.03%),对照组有8例(22.8%),两组比较,差异有统计学意义(P<0.05)。 结论:拉米夫定联合胸腺肽α1治疗慢性乙型肝炎疗效较好,值得临床应用。
    Results The markedly effective rate the total effective rate were 84.7% and 97.4% respectively in the treated group,and were obviously higher than that in the control group(52.1% and 91.2%,P<0.01).
    结果治疗组显效率为84.7%,总有效率为97.4%,对照组显效率为52.1%,总有效率为91.2%,治疗组显效率明显高于对照组,差异具有统计学意义。
    ②Average concentrations of oxygen free radicals: There was no significant difference in the control group before and after treatment (P > 0.05), while there was significant difference in the treated group.
    ②患者平均抗自由基能力:治疗前后对照组差异无显著性意义(P>0.05),治疗组差异有显著性意义; 对照组和治疗组治疗前差异无显著性意义(P>0.05);
    The rats in group A received no treated,group B and C received 0.1 g·L-1 and 0.5 g·L-1 N-acetylcysteine drops respectively,and group D received sodium phosphate balanced solution.
    B组和C组为糖尿病治疗组,分别给予0.1g. L-1与0.5g.
    There were 42 eyes with effective treatment in laser treated group and in 7 eyes in no laser treated group,there was significant difference between two groups(χ2=13.347,P=0.0003<0.01).
    激光治疗组治疗有效(无新生血管产生或新生血管减少或消退)42眼,非激光治疗组有效7眼,2组疗效比较,差异有显著统计学意义(χ2=13.347,P=0.0003<0.01)。
    Method:The model of middle cerebral artery occlusion(MCAO) and reperfusion was set up using an intraluminal filament method. Fifty Wistar male rats were randomly divided into sham operation group,ischemic group and 100mg/kg,300mg/kg curcumin treated group.
    方法:采用线栓法制作大鼠大脑中动脉缺血再灌注模型,50只Wistar雄性大鼠被随机分为假手术组、缺血组和100mg/kg、300mg/kg姜黄素治疗组
    Results Myocardial AngⅡand CTGF mRNA was expressed more in untreated group than that in normal controls and treated group(P<0.01).
    结果DM未治疗组心肌组织血管紧张素Ⅱ含量、CTGR mRNA的表达明显高于对照组和治疗组(P<0.01).
    TNF-α of XFC treated group were lower than that of model control group(P<0.01) and IL-10 of XFC treated group were higher than that of model control group(P<0.01),but there were no obvious differences among the three treated groups(P>0.05).
    与正常对照组比较,模型对照组IL-10显著降低(P<0.01); 与模型对照组比较,新风胶囊组IL-10显著升高(P<0.01),而与其余2治疗组无显著差异(P>0.05)。
    Treated group were given with IFNα-2b 6 million unit (MU), while control group was given with IFNα-2b 3MU, all every other day, Treatment 6 months.
    方法88例慢性乙型肝炎患者随机分为两组,治疗组用α2b干扰素6MU,对照组予α2b干扰素3MU,均为隔日1次肌注,疗程6个月。
    [Results] The end treatment, on ALT normalization rate, Treated group was 73.2 % and the control group was 50.0 %, on removing of HBeAg, Treated group was 51.9% and the control group was 28.1%, Treated group total efficacy (71.4%) was higher than the control group 50.0% (P <0.05).
    结果疗程结束时治疗组和对照组总有效率分别为71.4%,50.0%; 谷丙转氨酶(ALT)复常率为73.2%,50.0%;
    As compared with the model group,CCK-8 contents was increased in treated group(P < 0.01或P < 0.05).
    与模型组比较,治疗组下丘脑及血浆中CCK-8含量降低(P<0.01或P<0.05)。
    Results:TBil、DBil showed singnificantly difference(P<0.01)between treated group in 1month and 2months. Curative effect of treated group was better than control group,showing singnificantly difference(P<0.01).
    结果:2组比较,1个疗程后和2个疗程后总胆红素(TBil)、直接胆红素(DBil)差异均有显著性(P<0.01),治疗组疗效显著优于对照组(P<0.01)。
    The curative rate and total effective rate in the treated group were 63.33%(19/30)and 93.33%(29/30)respectively,significantly different to those in the control group 26.67%(8/30)and 63.33%,also different to those in the blank group 23.33%(3/30)and 10.00%,respectively(P<0.01).
    治疗组治愈率63.33%(19例),与对照组(26.67%,8例)及空白组(10.00%,3例)比较,差异有显著性(P<0.01); 总有效率93.33%,与对照组(63.33%)及空白组(33.33%)比较,差异有显著性(P<0.01);
    Along with the improving of sleep,blood pressure,both systolic and diastolic,reduced in both groups,but with the reduction in the treated group superior to that in the control group(P<0.01),and the rate of reaching target BP(<140/90 mmHg)in the former was also significantly higher than that in the latter(39.7%,46/116 cases,P<0.05).
    同时随着睡眠的改善,治疗组患者的血压(DBP和SBP)较对照组明显下降(P<0.001),目标血压(<140/90mmHg)的达标率〔53.7%(66/123例)〕也显著高于对照组〔39.7%(46/116例),P<0.05〕。
    MethodsThe model BXSB lupus mice were randomly divided into two groups equally,the ATO treated group and the control group,17 in each group. Mice in the ATO group were given intraperitoneal injection of ATO at the daily dose of 0.4 mg/kg,once every other day for 105 days or 90 days,respectively,and the observation lasted for 210 days.
    方法BXSB狼疮小鼠随机平分两组,即ATO治疗组和对照组,ATO0.4mg/(kg.d)隔日腹腔注射至90天和105天,观察至210天实验结束,比较两组小鼠生存时间的差异;
    ResultsTill the 210th day,the total number of death was 8 in the ATO treated group and 13 in the control group,comparison between the two groups showed significantly different(χ2=4.20,P<0.05).
    结果两组BXSB小鼠(每组各17只)生存时间比较,至210天时,ATO治疗组总死亡8只,而对照组总死亡13只,两组比较差异有显著性(χ2=4.20,P<0.05);
    TNFα of XFC treated group was lower than that of model group(P<0.01),and IL-10 of XFC treated group was higher than that of model group(P<0.01),but there was no obvious difference among the three treated groups(P>0.05).
    与正常组比较,模型组IL-10显著降低(P<0.01); 与模型组比较,XFC组IL-10显著升高(P<0.01),而与其余两个治疗组无显著差异(P>0.05)。
    Results Progressive stroke occurred in one case in treated group, and seven in control group(χ2=4.97,P<0.05).
    结果治疗组1例而对照组7例发生进展性卒中,两组比较差异有显著性(χ2=4.97,P<0.05);
 

首页上一页12345下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社